Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,876,524
  • Shares Outstanding, K 47,375
  • Annual Sales, $ 388,540 K
  • Annual Income, $ -13,360 K
  • EBIT $ 26 M
  • EBITDA $ 50 M
  • 60-Month Beta 1.59
  • Price/Sales 4.22
  • Price/Cash Flow 47.45
  • Price/Book 4.26

Options Overview Details

View History
  • Implied Volatility 57.39% (-3.97%)
  • Historical Volatility 24.49%
  • IV Percentile 39%
  • IV Rank 7.62%
  • IV High 343.80% on 11/28/25
  • IV Low 33.76% on 08/12/25
  • Expected Move (DTE 9) 2.17 (5.37%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 149
  • Open Int (30-Day) 142
  • Expected Range 38.17 to 42.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.14
  • Number of Estimates 1
  • High Estimate 0.14
  • Low Estimate 0.14
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.08 +3.22%
on 02/09/26
45.41 -11.16%
on 01/22/26
-4.01 (-9.04%)
since 01/09/26
3-Month
39.08 +3.22%
on 02/09/26
48.25 -16.39%
on 12/17/25
-4.64 (-10.32%)
since 11/10/25
52-Week
21.97 +83.61%
on 04/09/25
48.25 -16.39%
on 12/17/25
+9.82 (+32.18%)
since 02/10/25

Most Recent Stories

More News
What To Expect From Artivion’s (AORT) Q4 Earnings

What To Expect From Artivion’s (AORT) Q4 Earnings

AORT : 40.34 (+1.84%)
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting

1-Year Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate High Patient Survival with Low Morbidity

AORT : 40.34 (+1.84%)
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results

ATLANTA , Jan. 29, 2026 /PRNewswire/ --  Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter 2025 financial...

AORT : 40.34 (+1.84%)
2 Stocks Under $50 to Research Further and 1 We Avoid

2 Stocks Under $50 to Research Further and 1 We Avoid

AMSC : 31.88 (+10.73%)
MIR : 23.44 (-2.70%)
AORT : 40.34 (+1.84%)
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds

1 Profitable Stock with Exciting Potential and 2 Facing Headwinds

DE : 593.41 (+1.32%)
AORT : 40.34 (+1.84%)
RJF : 158.48 (-8.75%)
1 Healthcare Stock on Our Watchlist and 2 We Ignore

1 Healthcare Stock on Our Watchlist and 2 We Ignore

CI : 287.81 (-2.24%)
NEOG : 10.73 (+1.13%)
AORT : 40.34 (+1.84%)
3 Reasons to Sell AORT and 1 Stock to Buy Instead

3 Reasons to Sell AORT and 1 Stock to Buy Instead

AORT : 40.34 (+1.84%)
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid

1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid

CNMD : 42.80 (+2.71%)
ENSG : 203.93 (+2.33%)
AORT : 40.34 (+1.84%)
3 Cash-Producing Stocks with Questionable Fundamentals

3 Cash-Producing Stocks with Questionable Fundamentals

HLF : 16.67 (+0.97%)
BKD : 16.29 (+0.06%)
AORT : 40.34 (+1.84%)
Artivion (AORT) Stock Is Up, What You Need To Know

Artivion (AORT) Stock Is Up, What You Need To Know

AORT : 40.34 (+1.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 42.27
2nd Resistance Point 41.63
1st Resistance Point 40.99
Last Price 40.34
1st Support Level 39.71
2nd Support Level 39.07
3rd Support Level 38.43

See More

52-Week High 48.25
Last Price 40.34
Fibonacci 61.8% 38.21
Fibonacci 50% 35.11
Fibonacci 38.2% 32.01
52-Week Low 21.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar